Tango Therapeutics, Inc. (TNGX) Form 8-K — Aug 6, 2026
Dr. Barbara Weber's employment as Executive Chair of Tango Therapeutics ended on August 3, 2026, in accordance with the terms of her Amended and Restated Employment Agreement dated January 8, 2026. Upon the termination of her employment, she was deemed to have resigned from all officer and board member positions, including her seat on the company's board of directors. The filing states that Dr.
Key figures
- Severance Period
- base salary through December 31, 2026
- Cobra Reimbursement Through
- December 31, 2026
- Employment Termination Date
- August 3, 2026
- Vesting Acceleration Months
- 12
- Incentive Comp Payment Deadline
- no later than March 15, 2027
- Extended Option Exercise Deadline
- earlier of August 3, 2027 or original option expiration
Price after filing
1 day: -6.7%7 days: -11.6%30 days: -22.3%
Close on the filing date to close N calendar days later (from $29.00). Historical, not a forecast.
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.